Statistics
Publications
69
Citations
5.6K
H-Index
38
Active since
1993
Paul Bamborough is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicinal chemistry, and pharmacology.
Publications per year
1993–2022
69
69
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 428 citations · Full text
Comprehensive characterization of the Published Kinase Inhibitor Set
Jonathan M. Elkins, Vita Fedele, M. Szklarz et al. · Nature Biotechnology · 2015 · 350 citations
1–5 of 69